leader

Sharon Rosenzweig-Lipson

Chief Scientific Officer of Life Biosciences

Chief Scientific Officer, Life Biosciences

Background

Sharon Rosenzweig-Lipson, Ph.D., is the Chief Scientific Officer of Life Biosciences.

She reported positive non-human primate data for the OSK eye approach in 2024, according to Lifespan Magazine.

About Life Biosciences

Life Biosciences: Life Biosciences is a biotechnology company that develops cellular rejuvenation medicines to reverse diseases of aging.

Key facts

Title: Chief Scientific Officer, Life Biosciencessource
Interim data: Quoted on the ER-100 interim results released October 8, 2026source
Prior data: Reported positive data in non-human primates in 2024source

WYDE coverage of Sharon Rosenzweig-Lipson

WYDE Newsroom has published one article about Sharon Rosenzweig-Lipson, on Oct 9, 2026. Sharon Rosenzweig-Lipson is a named leader in 1 story. The most recent is Life Bio's ER-100 Shows Early Vision Signals in 2 of 3 Glaucoma Patients.

Healthcare

Life Bio's ER-100 Shows Early Vision Signals in 2 of 3 Glaucoma Patients

Life Biosciences reported interim Phase 1 results for ER-100, a gene therapy that delivers three genes to the eye, in three patients with open-angle glaucoma.

Oct 9, 2026 · 3 min read · Quoted or named as leader

Reported alongside Sharon Rosenzweig-Lipson

Life Biosciences · in 1 story with Sharon Rosenzweig-Lipson

Sources

Follow the money in philanthropy.

Who gives, who receives, and what it funds. Every week.